Skip to main content
Nirav Commercials Ltd. logo

Nirav Commercials Ltd. — Investor Relations & Filings

Ticker · 512425 ISIN · INE242B01018 BSE.NS Manufacturing
Open in API
Filings indexed 274 across all filing types
Latest filing 2023-01-17 Regulatory Filings
Country IN India
Listing BSE.NS 512425

About Nirav Commercials Ltd.

http://www.associatedgroup.com/NCL/

Nirav Commercials Ltd. specializes in the production and supply of aluminum packaging products. Its core operations involve the manufacturing of aluminum collapsible tubes and containers, which serve as essential packaging components for the pharmaceutical, cosmetic, and chemical sectors. The company also maintains a presence in trading and investment activities. By focusing on precision manufacturing and material durability, the firm provides specialized solutions intended to preserve the quality and safety of consumer and industrial goods. Its business model integrates manufacturing capabilities with commercial trading to address diverse market demands for protective packaging.

Recent filings

Filing Released Lang Actions
NIRAV COMMERCIALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve In terms of the provisions ....
Regulatory Filings Classification · 95% confidence The document is a letter from Nirav Commercials Limited addressed to BSE Ltd. Corporate Relationship Department. It informs about the scheduled meeting of the Board of Directors to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2022. The letter references Regulation 29 of the SEBI Listing Regulations, which pertains to disclosures about board meetings. The document does not contain the financial results themselves but is an announcement of the upcoming board meeting where such results will be approved. The document length is short (2027 characters) and serves as an intimation rather than a report or detailed financial disclosure. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-01-17 English
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we are attached herewith a copy of the Certificate dated 6th January, 2023, received from M/s ....
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialization activities for the quarter ended December 31, 2022. It is a compliance certificate from the Registrar and Share Transfer Agent to the stock exchange. The document is short (3472 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and miscellaneous regulatory documents that do not fit other specific categories.
2023-01-09 English
Pursuant to the provisions of the PIT Regulations, 2015 and in accordance with the Company''s Code of conduct to regulate, monitor and report trades in securities by Designated Persons, ....
Regulatory Filings Classification · 95% confidence The document is a notice from Nirav Commercials Limited addressed to the stock exchange regarding the closure of the trading window in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. It informs about the trading window closure period around the dissemination of the company's unaudited financial results for the third quarter and nine-month period ending December 31, 2022. The document is short (1810 characters) and serves as an announcement related to regulatory compliance and trading restrictions, not the financial results themselves or any detailed report. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-12-29 English
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, enclosing herewith disclosure of Related Party ....
Regulatory Filings Classification · 95% confidence The document is a disclosure of Related Party Transactions for the half year ended 30th September 2022, submitted to the stock exchange (BSE Ltd.) as per SEBI Listing Regulations. It contains detailed tabular data on related party transactions, including loans, rent, interest, and approvals by the audit committee. The document is a regulatory disclosure filing rather than a full financial report or management discussion. It is not an annual or interim report, earnings release, or audit report. It is a compliance disclosure under listing obligations, which fits best under Regulatory Filings (RNS). The document length is 4350 characters, which is relatively short and focused on a specific regulatory disclosure. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-11-18 English
Publication of Unaudited Financial Results for the 2nd quarter ended on 30th September, 2022
Regulatory Filings
2022-11-15 English
The Board of Directors of the Company at their meeting held today and concluded at 4.30 pm has approved the 'Unaudited Financial Results' of the Company for the Second Quarter ended 30th ....
Regulatory Filings
2022-11-14 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.